News by Tag: Biosimilars
Strong Biosimilars Segment Driving Asia Pacific Biotech Market
June 6, 2012
Biosimilars are fuelling growth in the Asia Pacific's biotechnology market says RNCOS' latest research study.
June 6, 2012
Biosimilars are fuelling growth in the Asia Pacific's biotechnology market says RNCOS' latest research study.
Asia Pacific Biotechnology Market Poised to Grow Significantly
April 12, 2012
The Asia Pacific Biotechnology Market will grow at a CAGR of around 19% during 2010 -2013, estimates RNCOS latest research study.
April 12, 2012
The Asia Pacific Biotechnology Market will grow at a CAGR of around 19% during 2010 -2013, estimates RNCOS latest research study.
Asia-Pacific Biotechnology Market Surging Ahead with a 19% Growth
February 29, 2012
The Asia-Pacific biotechnology market is likely to grow at a CAGR of around 19% during 2010-2013, acknowledged RNCOS.
February 29, 2012
The Asia-Pacific biotechnology market is likely to grow at a CAGR of around 19% during 2010-2013, acknowledged RNCOS.
Amgen to be the Worst Hit from US Biosimilar Erosion During 2011 - 2020
October 11, 2011
A new report from IMARC Group expects Amgen to lose brand sales worth US$ 8.4 Billion during 2010 and 2020 mainly as a result of biosimilar erosion.
October 11, 2011
A new report from IMARC Group expects Amgen to lose brand sales worth US$ 8.4 Billion during 2010 and 2020 mainly as a result of biosimilar erosion.
Korean Biotech Industry Set for Incessant Growth
August 30, 2011
The biotech market in South Korea is forecasted to grow at a CAGR of around 35% during 2010-2013, says RNCOS in its latest research study.
August 30, 2011
The biotech market in South Korea is forecasted to grow at a CAGR of around 35% during 2010-2013, says RNCOS in its latest research study.
The Market for Biosimilars Will be a Marathon and Not a Sprint
July 27, 2011
A new report from IMARC Group expects the US biosimilar market to reach revenues worth US$ 11.4 Billion by 2020. This market, however, unlike small molecule generics, is expected to be a marathon and not a sprint.
July 27, 2011
A new report from IMARC Group expects the US biosimilar market to reach revenues worth US$ 11.4 Billion by 2020. This market, however, unlike small molecule generics, is expected to be a marathon and not a sprint.
Temperature sensitivity of biological products driving the global cold chain logistics market
July 14, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
July 14, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
Temperature sensitivity of biological products driving the global cold chain logistics market
July 14, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
July 14, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
Temperature sensitivity of biological products driving the global cold chain logistics market
July 14, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
July 14, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
South Korea Asserting its Contribution in the Asia Pacific Biotech Market
June 28, 2011
The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research.
June 28, 2011
The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research.
View Page: [1] 2